KOSÉ, I Peace, and Reju to Revolutionize Personalized Beauty with iPS Cells
In a groundbreaking move, KOSÉ Corporation, I Peace, Inc., and Reju, Inc. have announced a strategic partnership aimed at developing personalized beauty products using iPS cells. This collaboration brings together the expertise of KOSÉ in beauty products, I Peace’s advancements in iPS cell technology, and Reju’s innovation in iPSF (iPS cell extract) to create customized […]
Exploring the Frontier of Stem Cell Technology: Century Therapeutics’ Latest Breakthroughs at ASGCT 2024
Century Therapeutics is making significant strides in the field of stem cell therapy, particularly with their induced pluripotent stem cell (iPSC) technology, which was showcased at the 2024 ASGCT Annual Meeting. The company presented compelling preclinical data, emphasizing advancements in treating autoimmune diseases and enhancing the survivability of allogeneic cell therapies against natural killer (NK) […]
Strategic Partnership Boosts iPSC-Derived Therapeutic Development
Theragent Inc., a leader in cell- and tissue-based therapies, has announced a partnership with Pluristyx Inc., a biotech specializing in induced Pluripotent Stem Cell (iPSC) products. This collaboration aims to provide a comprehensive pathway from iPSC derivation to the commercial production of iPSC-derived drug products, promising a streamlined approach to therapeutic development. Under the partnership, […]
Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award
Dr. Andrés Bratt-Leal, co-founder and Senior Vice President of Research and Development at Aspen Neuroscience, has been honored with the prestigious 2023 Biocom California Life Science Catalyst Award. This accolade, presented by Biocom California, recognizes the most inspiring and driven young minds in the California life sciences industry who are making significant contributions to human […]
Revolutionizing Treatment: Century Therapeutics and FUJIFILM’s Groundbreaking Alliance to Combat Autoimmune Diseases with Stem Cell Therapies
In a significant development for the treatment of autoimmune and inflammatory diseases, Century Therapeutics, Inc., a trailblazing biotechnology company, and FUJIFILM Cellular Dynamics, Inc., a prominent developer and manufacturer of human induced pluripotent stem cells (iPSCs) and iPSC-derived cells, have announced a worldwide license agreement. This collaboration is set to advance the development and commercialization […]
REPROCELL and Gameto Collaborate to Enhance Assisted Fertility Using iPSCs
REPROCELL Inc. has recently announced a licensing agreement with Gameto Inc., a female-led biotech firm dedicated to transforming women’s healthcare. This agreement grants Gameto a non-exclusive right to utilize REPROCELL’s StemRNA™ Clinical Seed iPSCs. Gameto intends to leverage this clinical-grade iPSC line for the development and commercialization of its innovative program, Fertilo, which aims to […]
Revolution in Cancer Treatment: LIfT’s iPSCs Breakthrough
LIfT BioSciences, a rapidly emerging biotech company, has announced a significant breakthrough in cancer cell therapies. The company has successfully demonstrated proof-of-concept production of its patented cancer-killing alpha neutrophils from induced pluripotent stem cells (iPSCs). This development marks a new era of affordable and effective cancer cell therapies. The company’s second-generation platform, iN-LIfT, derived from […]
Induced Pluripotent Stem Cells (iPSCs): Creation and Applications
Welcome, dear readers! Today, we’re embarking on a journey into the microscopic world of cells, specifically stem cells. These aren’t just any ordinary cells; they’re like the superheroes of the cellular world. Imagine a cell that can morph into any cell type in the body, much like a superhero changing disguises. That’s the power of […]
Exploring the Use of Induced Pluripotent Stem Cells in Healing
Stem cell therapy has been gaining much attention in recent years as a potential therapy for various medical conditions. One type of stem cell that is currently being used in therapeutic applications is induced pluripotent stem cells (iPSCs). These cells are generated from adult cells and can be reprogrammed to behave like embryonic stem cells, […]
Stem Cell Therapy Shows Promise for Age-Related Macular Degeneration
A recent study has demonstrated the potential of stem cell therapy as a treatment for age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Researchers from the RIKEN Center for Biosystems Dynamics Research have developed a new method of transforming stem cells into retinal cells, which has shown promising results in […]